ArticleDiabetology international2022

Combined treatment with glucagon-like peptide-1 receptor agonist exendin-4 and metformin attenuates breast cancer growth.

Yuki Tanaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.